LASP1 facilitates bladder cancer progression through binding and downregulating MYH9 to inhibit mitochondrial
Ke Wang1, Zewei Hu1, Yihao Zhu2
1Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, China.
Abstract:
LIM and SH3 protein 1 (LASP1) plays a crucial role in tumorigenesis and metastasis, but its function in bladder cancer remains unclear. Here, we found that LASP1 was markedly upregulated in bladder cancer tissues and correlated with poor prognosis. Co-immunoprecipitation and mass spectrometry identified MYH9 as a direct LASP1-binding partner, with the interaction mediated by the SH3 domain of LASP1 and the M2 domain of MYH9. Functional assays revealed that LASP1 maintained mitochondrial morphology and function by regulating MYH9, thereby preventing mitochondrial damage-induced apoptosis and promoting cell proliferation and migration. In vitro and in vivo experiments consistently demonstrated that the LASP1-MYH9 axis enhances bladder cancer growth and metastasis. Overall, our findings reveal that LASP1 facilitates bladder cancer progression by interacting with MYH9 to inhibit mitochondria-mediated apoptosis, and provide a rationale for further exploring the LASP1-MYH9 axis in bladder cancer therapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic cells are...

